Coxibs and cardiovascular risk

CMAJ. 2005 Oct 11;173(8):853. doi: 10.1503/cmaj.1050119.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis / drug therapy*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Cardiovascular Diseases / etiology*
  • Celecoxib
  • Clinical Trials as Topic
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Dose-Response Relationship, Drug
  • Humans
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib
  • Aspirin